# Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer

> **NCT04113096** · EARLY_PHASE1 · UNKNOWN · sponsor: **The University of The West Indies** · enrollment: 104 (estimated)

## Conditions studied

- Stage IV Prostate Cancer
- Stage IV Colon Cancer
- Stage IV Breast Cancer
- Stage IV Cancer of the Cervix

## Interventions

- **DRUG:** Dibenzyl trisulphide capsules
- **DRUG:** Dibenzyl trisulphide capsules
- **DRUG:** Dibenzyl trisulphide capsules
- **DRUG:** Dibenzyl trisulphide capsules
- **DRUG:** Stage IV Breast Cancer Placebo
- **DRUG:** Stage IV: Colon Cancer Placebo
- **DRUG:** Cervical Cancer Stage IV Placebo
- **DRUG:** Cancer of the Prostate Placebo

## Key facts

- **NCT ID:** NCT04113096
- **Lead sponsor:** The University of The West Indies
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2019-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04113096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04113096, "Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04113096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*